Identification of Structurally Diverse Antimicrobials Through Sequential Application of Pharmacophore Modeling, Virtual Screening, Molecular Docking and In Vitro Microbiological Assay.

about

Identification of Structurally Diverse Antimicrobials Through Sequential Application of Pharmacophore Modeling, Virtual Screening, Molecular Docking and In Vitro Microbiological Assay.

Item

http://www.wikidata.org/entity/Q39944839

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Identification of Structurally ...... n Vitro Microbiological Assay.

@en

Identification of Structurally ...... n Vitro Microbiological Assay.

@nl

type

Item

label

Identification of Structurally ...... n Vitro Microbiological Assay.

@en

Identification of Structurally ...... n Vitro Microbiological Assay.

@nl

prefLabel

Identification of Structurally ...... n Vitro Microbiological Assay.

@en

Identification of Structurally ...... n Vitro Microbiological Assay.

@nl

P1476

Identification of Structurally ...... In Vitro Microbiological Assay

@en

P2093

Ankita Agarwal

http://www.w3.org/2001/XMLSchema#string

Ruchi Mishra

http://www.w3.org/2001/XMLSchema#string

Sarvesh Paliwal

http://www.w3.org/2001/XMLSchema#string

P2860

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase

Pharmacophore identification and virtual screening for methionyl-tRNA synthetase inhibitors.

3-D pharmacophores in drug discovery.

Development of a robust QSAR model to predict the affinity of pyrrolidine analogs for dipeptidyl peptidase IV (DPP- IV).

Conformational sampling of druglike molecules with MOE and catalyst: implications for pharmacophore modeling and virtual screening.

2,4-Diamino-5-methyl-6-substituted arylthio-furo[2,3-d]pyrimidines as novel classical and nonclassical antifolates as potential dual thymidylate synthase and dihydrofolate reductase inhibitors.

Potent in vitro and in vivo antitoxoplasma activity of the lipid-soluble antifolate trimetrexate

In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features

3D QSAR pharmacophore modeling, in silico screening, and density functional theory (DFT) approaches for identification of human chymase inhibitors.

P2888

s12539-016-0156-9

P304

332-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12539-016-0156-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Swapnil Sharma

P577

2016-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26947220

http://www.w3.org/2001/XMLSchema#string